3188 results for «2124»
3188 results
Expanding horizons in coronary calcified lesion management with intravascular lithotripsy
10 Oct 2025 – From AICT-AsiaPCR 2025
This session highlights advancements in managing coronary calcified lesions through intravascular lithotripsy using the Shockwave system. It discusses the unique mechanism of action for different calcium morphologies, reviews the latest clinical data, and addresses complex scenarios including diffuse lesions and challenging nodular or eccentric calcium deposits,...
New insights into mechanical circulatory support: Impella in CGS and protected PCI
10 Oct 2025 – From AICT-AsiaPCR 2025
This session provides in-depth insights into the evolving role of mechanical circulatory support, focusing on the use of Impella devices in cardiogenic shock (CGS) and protected high-risk percutaneous coronary interventions (PCI). Attendees will gain knowledge on patient selection criteria, the impact of the DanGer trial and...
Coronary interventions: access, devices and outcomes
10 Oct 2025 – From AICT-AsiaPCR 2025
This session delves into the latest developments in coronary interventions, highlighting advances in vascular access techniques, innovative devices, and clinical outcomes. Topics include endothelial progenitor cell dysfunction in restenosis, the efficacy of distal radial artery (DRA) puncture and sheathless catheters in underserved areas, the use of...
NSTEMI, complex ACS and anatomy
10 Oct 2025 – From AICT-AsiaPCR 2025
This session focuses on complex cases involving non-ST elevation myocardial infarction (NSTEMI), acute coronary syndromes (ACS), and challenging coronary anatomy. It presents unique clinical scenarios such as pediatric rescue PCI, management of significant distal lesions with proximal PCI, anatomical variations complicating interventions, mixed cardiovascular disease management,...
Valve-in-valve in degenerated surgical bioprothesis mitral valve - LIVE Case
10 Oct 2025 – From AICT-AsiaPCR 2025
A 78-year-old male with a history of rheumatic disease underwent surgical mitral valve replacement (Perimount Magna 25), surgical aortic valve replacement (Perimount Magna), and CABG (LIMA–LAD) in 2010. He presented with symptomatic severe mitral regurgitation and normal LV function.
He was treated with implantation of a 26...
STEMI, thrombus and emergencies
10 Oct 2025 – From AICT-AsiaPCR 2025
Focused on STEMI and acute thrombotic emergencies, this session presents a series of challenging cases involving heavy thrombus burden, acute total occlusions, and complex primary angioplasty scenarios. It explores innovative approaches beyond stenting, the role of drug-coated balloons in plaque erosion, and strategic decision-making in managing...
TRISCEND: six-month outcomes of transfemoral tricuspid valve replacement in patients with TR - a written review
09 Nov 2021
The 6-month follow-up of the TRISCEND study was presented during the TCT Congress 2021 by principal investigator Susheel Kodali. Alessandro Sticchi & Jonathan Curio offer a review of this trial.
Author
Author
Drug-coated balloon (DCB) technology: A pioneer’s view of the historical evolution and future directions
08 Jan 2025
In this article, Bruno Scheller explores advances in local drug delivery, from drug-coated balloons to novel antiproliferative agents. These innovations aim to reduce restenosis, minimize permanent implants, and pave the way for patient-specific coronary artery disease treatments.
Author
